mFlusiva becomes the first mRNA influenza vaccine approved by the FDA
1. The FLUENT trial demonstrated 26.6% relative vaccine efficacy over a standard-dose comparator in adults 50 and older, clearing the ...
1. The FLUENT trial demonstrated 26.6% relative vaccine efficacy over a standard-dose comparator in adults 50 and older, clearing the ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. FDA ...
1. The first dose of adenoviral-based Oxford-AstraZeneca and Janssen vaccines was associated with acute myocardial infarction and pulmonary embolism. 2. ...
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable protection against hospitalization and death. 2. However, ...
Section 2: Moderna Vaccine Second to Receive Emergency Use Authorization The FDA Advisory Committee met on December 17, 2020, ultimately ...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in